Back
Rigel Pharmaceuticals 10K Form
Buy
54
RIGL
Rigel Pharmaceuticals
Last Price:
14.80
Seasonality Move:
14.12%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
| 2023-11-07 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
| 2023-08-01 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
| 2023-05-02 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
| 2022-11-03 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
| 2022-08-02 | 10Q | RIGL/Rigel Pharmaceuticals Quarterly |
Receive RIGL News And Ratings
See the #1 stock for the next 7 days that we like better than RIGL
RIGL Financial Statistics
Sales & Book Value
| Annual Sales: | $116.88M |
|---|---|
| Cash Flow: | $80K |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-1.70 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.76000 |
|---|---|
| Net Income (TTM): | $-14.23M |
| Gross Margin: | $109.77M |
| Return on Equity: | 0% |
| Return on Assets: | -11.77% |
Rigel Pharmaceuticals Earnings Forecast
Key Rigel Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 25 years for RIGL is 93.92%.
- The Selling, General & Administrative Expenses for RIGL have been equal to 90.47% of Gross Profit Margin.
- The Research & Development expenses have been 20.98% of Revenue.
- The Interest Expense is -27.39% of Operating Income.
- The Net Earning history of RIGL is -21.47% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 17 years.
Rigel Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | RIGL |
| CUSIP: | 766559 |
| Website: | rigel.com |
Debt
| Debt-to-Equity Ratio: | -2 |
|---|---|
| Current Ratio: | 1.62 |
| Quick Ratio: | 1.33 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 19.36 |
RIGL Technical Analysis vs Fundamental Analysis
Buy
54
Rigel Pharmaceuticals (RIGL)
is a Buy
Is Rigel Pharmaceuticals a Buy or a Sell?
-
Rigel Pharmaceuticals stock is rated a Buy
The current Rigel Pharmaceuticals [RIGL] share price is $14.50. The Score for RIGL is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.